Breast Cancer Prevention Drug Endoxifen Shows Promise at Low Doses
A randomized trial shows low-dose endoxifen reduces breast density similarly to tamoxifen, with improved tolerability, highlighting its potential as a safer pre...
A randomized trial shows low-dose endoxifen reduces breast density similarly to tamoxifen, with improved tolerability, highlighting its potential as a safer preventive therapy for breast cancer. The post Breast Cancer Prevention Drug Endoxifen Shows Promise at Low Doses appeared first on Inside Precision Medicine .